Randomised, phase II, placebo-controlled, trial of fulvestrant plus vandetanib in postmenopausal women with bone only or bone predominant, hormone-receptor-positive metastatic breast cancer (MBC): The OCOG ZAMBONEY study

Mark J. Clemons, Brandy Cochrane, Gregory R. Pond, Nadia Califaretti, Stephen K.L. Chia, Rebecca Alexandra Dent, Xinni Song, Andre Robidoux, Sameer Parpia, David Warr, Daniel Rayson, Kathleen I. Pritchard, Mark N. Levine

科研成果: 期刊稿件文章同行评审

43 引用 (Scopus)
源语言英语
页(从-至)153-162
页数10
期刊Breast Cancer Research and Treatment
146
1
DOI
出版状态已出版 - 7月 2014
已对外发布

!!!ASJC Scopus Subject Areas

  • 肿瘤学
  • 癌症研究

指纹

探究 'Randomised, phase II, placebo-controlled, trial of fulvestrant plus vandetanib in postmenopausal women with bone only or bone predominant, hormone-receptor-positive metastatic breast cancer (MBC): The OCOG ZAMBONEY study' 的科研主题。它们共同构成独一无二的指纹。

引用此